<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://biotechmorning.com/news/bbo-8520-kras-g12c-resistant-lung-cancer</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T14:18:03.247Z</news:publication_date>
      <news:title>The Lung Cancer Drug That Works After Everything Else Stops</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/pharvaris-oral-hae-pill-phase-3-win</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T14:17:15.203Z</news:publication_date>
      <news:title>The Pill That Wants to Replace Your Needle</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/intellia-crispr-lonvo-z-fda-priority-review</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T14:16:29.920Z</news:publication_date>
      <news:title>One Shot to Rewrite Your DNA: The CRISPR Therapy Knocking on the FDA&apos;s Door</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/astrazeneca-tozorakimab-copd-biologic</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T14:15:39.719Z</news:publication_date>
      <news:title>AstraZeneca Just Crashed the Inhaler Party With a $5B Biologic</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/novartis-del-desiran-harbor-trial-failure</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T14:14:54.862Z</news:publication_date>
      <news:title>Novartis Bet $12 Billion on This Drug. It Just Flopped.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/ox40-agonist-inhibrx-comeback</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T14:14:08.322Z</news:publication_date>
      <news:title>The Immunotherapy Target Everyone Gave Up On Just Came Back to Life</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/roivant-mosliciguat-pulmonary-hypertension-10-billion</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T14:13:22.517Z</news:publication_date>
      <news:title>Roivant&apos;s Lung Drug Just Posted Data That Has Wall Street Buzzing</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/blood-test-catches-breast-cancer-fighting-back</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T14:12:37.870Z</news:publication_date>
      <news:title>The Blood Test That Catches Breast Cancer Fighting Back</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/sclc-imdelltra-imfinzi-survival-win</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-09T14:11:48.903Z</news:publication_date>
      <news:title>The Cancer That Keeps Winning Just Lost a Round</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/novartis-avidity-12-billion-bet-lost</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T14:17:14.894Z</news:publication_date>
      <news:title>Novartis Spent $12 Billion on a Bet. The Bet Just Lost.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/sclc-bispecific-immunotherapy-survival-benefit</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T14:16:26.308Z</news:publication_date>
      <news:title>The Cancer That Barely Flinched at Immunotherapy Just Met Its Match</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/merck-10-billion-verona-pharma-copd-bet</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T14:15:41.387Z</news:publication_date>
      <news:title>Merck Just Bet $10 Billion on a COPD Drug. Here&apos;s Why.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/moderna-2-6-billion-oncology-bet</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T14:14:55.816Z</news:publication_date>
      <news:title>Moderna Just Bet $2.6 Billion That mRNA Can Kill Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/lilly-merida-biosciences-autoimmune-acquisition</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T14:14:07.623Z</news:publication_date>
      <news:title>Lilly&apos;s $2.9B Bet on a Disease Most People Have Never Heard Of</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/base-editing-sickle-cell-thalassemia-remission</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T14:13:19.209Z</news:publication_date>
      <news:title>The Gene Editor That Didn&apos;t Cut Anything Just Cured Sickle Cell</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/semaglutide-step-young-children-obesity-results</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T14:12:29.777Z</news:publication_date>
      <news:title>Novo Nordisk Just Gave Wegovy to Six-Year-Olds. It Worked.</news:title>
    </news:news>
  </url>
</urlset>